Its four CAD risk candidate genes (LDLR, APOE, SCARB1, and NOS3) (Fig. 3A and Supplementary Tables 1 and 8) are well-established in lipoprotein and nitric oxide/cGMP metabolism and have been identified as candidate genes by GWAS1,53,54. This evidence concerns the gene APOE and coronary artery disorder.